Literature DB >> 17826804

General anesthetics selectively modulate glutamatergic and dopaminergic signaling via site-specific phosphorylation in vivo.

Gretchen L Snyder1, Stacey Galdi, Joseph P Hendrick, Hugh C Hemmings.   

Abstract

Isoflurane, propofol and ketamine are representative general anesthetics with distinct molecular mechanisms of action that have neuroprotective properties in models of excitotoxic ischemic damage. We characterized the effects of these agents on neuronal glutamate and dopamine signaling by profiling drug-induced changes in brain intracellular protein phosphorylation in vivo to test the hypothesis that they affect common downstream effectors. Anesthetic-treated and control mice were killed instantly by focused microwave irradiation, frontal cortex and striatum were removed, and the phosphorylation profile of specific neuronal signaling proteins was analyzed by immunoblotting with a panel of phospho-specific antibodies. At anesthetic doses that produced loss of righting reflex, isoflurane, propofol, and ketamine all reduced phosphorylation of the activating residue T183 of ERK2 (but not of ERK1); S897 of the NR1 NMDA receptor subunit; and S831 (but not S845) of the GluR1 AMPA receptor subunit in cerebral cortex. At sub-anesthetic doses, these drugs only reduced phosphorylation of ERK2. Isoflurane and ketamine also reduced phosphorylation of spinophilin at S94, but oppositely regulated phosphorylation of presynaptic (tyrosine hydroxylase) and postsynaptic (DARPP-32) markers of dopaminergic neurotransmission in striatum. These data reveal both shared and agent-specific actions of CNS depressant drugs on critical intracellular protein phosphorylation signaling pathways that integrate multiple second messenger systems. Reduced phosphorylation of ionotropic glutamate receptors by all three anesthetics indicates depression of normal glutamatergic synaptic transmission and reduced potential excitotoxicity. This novel approach indicates a role for phosphorylation-mediated down-regulation of glutamatergic synaptic transmission by general anesthetics and identifies specific in vivo targets for focused evaluation of anesthetic mechanisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17826804     DOI: 10.1016/j.neuropharm.2007.07.008

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  19 in total

1.  Neonatal exposure of ketamine inhibited the induction of hippocampal long-term potentiation without impairing the spatial memory of adult rats.

Authors:  Dongyong Guo; Jianhui Gan; Tao Tan; Xin Tian; Guolin Wang; Kevin Tak-Pan Ng
Journal:  Cogn Neurodyn       Date:  2018-02-22       Impact factor: 5.082

2.  Differential effect of isoflurane, medetomidine, and urethane on BOLD responses to acute levo-tetrahydropalmatine in the rat.

Authors:  Xiping Liu; Rupeng Li; Zheng Yang; Anthony G Hudetz; Shi-Jiang Li
Journal:  Magn Reson Med       Date:  2011-12-28       Impact factor: 4.668

3.  Sensitivity to isoflurane anesthesia increases in autism spectrum disorder Shank3+/∆c mutant mouse model.

Authors:  Changsheng Li; Michele Schaefer; Christy Gray; Ya Yang; Orion Furmanski; Sufang Liu; Paul Worley; C David Mintz; Feng Tao; Roger A Johns
Journal:  Neurotoxicol Teratol       Date:  2016-11-14       Impact factor: 3.763

4.  Preserving protein profiles in tissue samples: differing outcomes with and without heat stabilization.

Authors:  Md Mahiuddin Ahmed; Katheleen J Gardiner
Journal:  J Neurosci Methods       Date:  2011-01-12       Impact factor: 2.390

5.  Blockade of serotonin 2A receptors prevents PCP-induced attentional performance deficit and CREB phosphorylation in the dorsal striatum of DBA/2 mice.

Authors:  Laura Pozzi; Barbara Greco; Giuseppina Sacchetti; Giampaolo Leoni; Roberto W Invernizzi; Mirjana Carli
Journal:  Psychopharmacology (Berl)       Date:  2009-12-08       Impact factor: 4.530

6.  Regional differences in the effects of isoflurane on neurotransmitter release.

Authors:  Robert I Westphalen; No-Bong Kwak; Keir Daniels; Hugh C Hemmings
Journal:  Neuropharmacology       Date:  2011-05-30       Impact factor: 5.250

Review 7.  [Postoperative cognitive dysfunction. Possible neuronal mechanisms and practical consequences for clinical routine].

Authors:  R Haseneder; E Kochs; B Jungwirth
Journal:  Anaesthesist       Date:  2012-05       Impact factor: 1.041

8.  Propofol selectively alters GluA1 AMPA receptor phosphorylation in the hippocampus but not prefrontal cortex in young and aged mice.

Authors:  Li-Min Mao; James M Hastings; Eugene E Fibuch; John Q Wang
Journal:  Eur J Pharmacol       Date:  2014-06-04       Impact factor: 4.432

9.  NMDA receptor phosphorylation at a site affected in schizophrenia controls synaptic and behavioral plasticity.

Authors:  Bo Li; Nino Devidze; Denis Barengolts; Naseem Prostak; Eleana Sphicas; Alfonso J Apicella; Roberto Malinow; Effat S Emamian
Journal:  J Neurosci       Date:  2009-09-23       Impact factor: 6.167

10.  Propofol at clinically relevant concentrations increases neuronal differentiation but is not toxic to hippocampal neural precursor cells in vitro.

Authors:  Jeffrey W Sall; Greg Stratmann; Jason Leong; Elliott Woodward; Philip E Bickler
Journal:  Anesthesiology       Date:  2012-11       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.